Reaching the Hard-to-Reach: Outcomes of the Severe Hypertension Outreach Intervention.

Published

Journal Article

INTRODUCTION: Severe hypertension (≥180 mmHg systolic or ≥110 mmHg diastolic) is associated with a twofold increase in the relative risk of death. At the authors' Federally Qualified Health Center in the Southeast, 39% of adults (n=8,695) had hypertension, and 3% (n=235) were severe. The purpose of this project was to lower blood pressure and improve the proportion of patients achieving the Agency for Healthcare Research and Quality goal for blood pressure. METHODS: This quality improvement project was performed in 2017 in three 3-month Plan, Do, Study, Act cycles using a multidisciplinary outreach model in a community-based primary care setting. A clinical team including physicians, nurses, patient navigators, behavioral health counselors, and pharmacists contacted adult patients with severe hypertension (≥180/110 mmHg), scheduled visits, and established blood pressure and medication management goals. The data review and analysis concluded in 2019. RESULTS: Among patients with blood pressure ≥180/110 mmHg (n=235), the average age was 57 years (SD=12 years), 37% (n=87) were male, 82% (n=193) were Black, and 46% (n=108) were uninsured. The majority of those contacted attended a follow-up appointment within the 9-month project (77%, n=181) and achieved an improved systolic blood pressure (87%, n=167) and diastolic blood pressure (76%, n=146). Target blood pressure of <140/90 mmHg was achieved in 29% of patients (n=53). Medication possession ratio improved from 23% to 40% among patients reached by pharmacists (n=30). Fewer deaths occurred in those reached by the intervention than in those not reached (n=1 vs n=3). CONCLUSIONS: Multidisciplinary outreach and use of evidence-based guidelines (Eighth Joint National Committee) were associated with lower blood pressure in patients with severe hypertension.

Full Text

Duke Authors

Cited Authors

  • Biola, H; Deyo, J; Hayes, T; Small, L; Chaplin, J; Pak-Harvey, E; Granger, T; Jung, L; Fitzgerald, L; Crowder, C; Patel, B; Stillwell, T; Eisenson, H; Granger, B

Published Date

  • November 2020

Published In

Volume / Issue

  • 59 / 5

Start / End Page

  • 725 - 732

PubMed ID

  • 33011006

Pubmed Central ID

  • 33011006

Electronic International Standard Serial Number (EISSN)

  • 1873-2607

Digital Object Identifier (DOI)

  • 10.1016/j.amepre.2020.05.030

Language

  • eng

Conference Location

  • Netherlands